2) Pelvic ultrasound, TVUS: frequently shows ovaries of increased size due to a greater number of follicles (12 or more follicles measuring 2 to 9 mm in diameter) or an increased ovarian volume. Findings may be nonspecific.
3) Endometrial biopsy: unopposed estrogen from chronic anovulation (≥6 months) puts PCOS patients at higher risk for endometrial hyperplasia/cancer.
Criteria for Diagnosis: in addition to exclusion of related disorders: i) first-line treatment for anovulatory women who wish to conceive. 50 to 100 mg/day for 5 days at beginning of cycle.
ii) Restores menstrual regularity, iii) improves ovulation rate (NNT 2) clinical pregnancy rate (NNT 6).
iv) 80% will ovulate in response to treatment, and 50% of those will conceive. v) Pregnancy response usually occurs within the first six ovulatory cycles. Prolonged duration of treatment does not increase rate of pregnancy.
vi) Insufficient evidence that adding another agent can increase ovulation rates. ii) Risks can be reduced by using lower doses. The most frequently used dosing schedules are low dose step up and step down regimens. b) The reduction in multiple pregnancy rates in women undergoing LOD 2) Risks: adhesion formation, and potential surgical and anesthesia risks. There are ongoing concerns about long-term effects of LOD on ovarian function (POF).
3) Insufficient evidence for a) unilateral versus bilateral LOD b) laser versus diathermy;
